254 related articles for article (PubMed ID: 15697324)
1. Do atypical antipsychotics cause stroke?
Herrmann N; Lanctôt KL
CNS Drugs; 2005; 19(2):91-103. PubMed ID: 15697324
[TBL] [Abstract][Full Text] [Related]
2. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
van Marum RJ; Jansen PA
Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics and risk of cerebrovascular accidents.
Herrmann N; Mamdani M; Lanctôt KL
Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
[TBL] [Abstract][Full Text] [Related]
4. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Layton D; Harris S; Wilton LV; Shakir SA
J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
[TBL] [Abstract][Full Text] [Related]
5. Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.
Chiabrando G; Bianchi S; Poluzzi E; Montanaro N; Scanavacca P
Eur J Clin Pharmacol; 2010 Jul; 66(7):661-9. PubMed ID: 20464383
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
[TBL] [Abstract][Full Text] [Related]
7. A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.
Kryzhanovskaya LA; Jeste DV; Young CA; Polzer JP; Roddy TE; Jansen JF; Carlson JL; Cavazzoni PA
J Clin Psychiatry; 2006 Jun; 67(6):933-45. PubMed ID: 16848653
[TBL] [Abstract][Full Text] [Related]
8. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
9. [Atypical antipsychotics in elderly patients with dementia].
Selbaek G; Engedal K
Tidsskr Nor Laegeforen; 2008 May; 128(9):1060-1. PubMed ID: 18451888
[TBL] [Abstract][Full Text] [Related]
10. [The use of antipsychotics in patients with dementia].
Forlenza OV; Cretaz E; Diniz BS
Braz J Psychiatry; 2008 Sep; 30(3):265-70. PubMed ID: 18833428
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics.
Liperoti R; Gambassi G; Lapane KL; Chiang C; Pedone C; Mor V; Bernabei R
J Clin Psychiatry; 2005 Sep; 66(9):1090-6. PubMed ID: 16187764
[TBL] [Abstract][Full Text] [Related]
12. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics for nursing home patients: a retrospective chart review.
Frenchman IB
Drugs Aging; 2005; 22(3):257-64. PubMed ID: 15813657
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
Yury CA; Fisher JE
Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959
[TBL] [Abstract][Full Text] [Related]
16. Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review.
Sacchetti E; Turrina C; Valsecchi P
Drug Saf; 2010 Apr; 33(4):273-88. PubMed ID: 20297860
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
Zaudig M
Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
[TBL] [Abstract][Full Text] [Related]
19. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
Martin H; Slyk MP; Deymann S; Cornacchione MJ
J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
